Latest News:

NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine
CytoDyn Releases Mechanism of Action Animation for Leronlimab in Immuno-Oncology
BioLargo Engineering Completes Prototype for PFAS Treatment System and Prepares for First Pilot Projects
Cannabis Sativa, Inc. Reports Record First Quarter Revenues
Tongji Healthcare Group, Inc. Announces New Board of Directors

Stock Day Media

Ticker Tape by TradingView

News
Radio Show
- Be on our Show!
- Video Interviews
Technology
Cannabis
Energy
BioTech
Mining
Contact Us
- About Us
- Suggestion Box

Subscribe to the latest in micro-cap news and podcasts, straight to your inbox.
Subscribe Now

mateontherapeutics

MATEON IS SELECTED BY IBM WATSON HEALTH FOR THE USE OF IBM CLINICAL DEVELOPMENT SOLUTION AT NO COST FOR PHASE II CLINICAL TRIAL OF OT-101 FOR COVID-19

June 24, 2020June 24, 2020 Stock Day Media 510 Views clinicaltrial, covid19, covid9trial, IBM, mateontherapeutics, MATN, metoen

Mateon was approved to use the platform following a review of the program as part of IBM Watson Health’s effort

Read more

Mateon Announces Achievement of Milestone Under Licensing of OT-101/IL-2 Combination to Autotelic BIO

June 10, 2020June 10, 2020 Stock Day Media 186 Views autotelicBIO, mateon, mateontherapeutics, xenograft

The licensing agreement of OT-101 to Autotelic BIO with the field of use limited to OT-101 (Trabedersen) with Interleukin-2 (OT-101/IL-2)

Read more

Latest News

NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine

July 2, 2020 Stock Day Media Comments Off on NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine

NGIO has previously developed Ii-Key-H1 peptides for vaccines against epitopes to 2009 Swine Flu and 2004 Bird Flu with positive

CytoDyn Releases Mechanism of Action Animation for Leronlimab in Immuno-Oncology

July 2, 2020 Stock Day Media Comments Off on CytoDyn Releases Mechanism of Action Animation for Leronlimab in Immuno-Oncology

BioLargo Engineering Completes Prototype for PFAS Treatment System and Prepares for First Pilot Projects

July 2, 2020 Stock Day Media Comments Off on BioLargo Engineering Completes Prototype for PFAS Treatment System and Prepares for First Pilot Projects

Cannabis Sativa, Inc. Reports Record First Quarter Revenues

July 2, 2020 Stock Day Media Comments Off on Cannabis Sativa, Inc. Reports Record First Quarter Revenues

Copyright © 2020 Stock Day Media. All rights reserved.